Cargando…
miR-92a Corrects CD34(+) Cell Dysfunction in Diabetes by Modulating Core Circadian Genes Involved in Progenitor Differentiation
Autologous CD34(+) cells are widely used for vascular repair; however, in individuals with diabetes and microvascular disease these cells are dysfunctional. In this study, we examine expression of the clock genes Clock, Bmal, Per1, Per2, Cry1, and Cry2 in CD34(+) cells of diabetic and nondiabetic or...
Autores principales: | Bhatwadekar, Ashay D., Yan, Yuanqing, Stepps, Valerie, Hazra, Sugata, Korah, Maria, Bartelmez, Stephen, Chaqour, Brahim, Grant, Maria B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876760/ https://www.ncbi.nlm.nih.gov/pubmed/26283734 http://dx.doi.org/10.2337/db15-0521 |
Ejemplares similares
-
Transient Inhibition of Transforming Growth Factor-β1 in Human Diabetic CD34(+) Cells Enhances Vascular Reparative Functions
por: Bhatwadekar, Ashay D., et al.
Publicado: (2010) -
Liver X Receptor Modulates Diabetic Retinopathy Outcome in a Mouse Model of Streptozotocin-Induced Diabetes
por: Hazra, Sugata, et al.
Publicado: (2012) -
Enhancing the Function of CD34(+) Cells by Targeting Plasminogen Activator Inhibitor-1
por: Hazra, Sugata, et al.
Publicado: (2013) -
Per2 Mutation Recapitulates the Vascular Phenotype of Diabetes in the Retina and Bone Marrow
por: Bhatwadekar, Ashay D., et al.
Publicado: (2013) -
Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes
por: Luo, Qianyi, et al.
Publicado: (2022)